ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001337.1|Lazarimide_1 # 200 # 964 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.733	BGC0001337.1|Lazarimide_1 	200	964	+	Loose	500	24.6386	mphO	27.78	3004543	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGCCCACGAGCACCGCCGAAACCCAGCAGCGCACCACCGTGCGCACCCACGACGGCCTGCGCCTGGCCGGCACGCTGGTCGCACCAGAGCCCGAACCGAAGCGCGCGGTGCTGTTGCTGCACGGTGAGGGATCGACGAGCGACCAGGGCGGCTTCTACGCGCGGCTGTCCGCCGAGCTCGCCGAACGCGGCGTGGCCAGCCTGCGCTTCGACCTGCCGGGCCACGGCGACAGCGAGGGCCGCCAGGAGGACCTGACCCTGTCCGGCCTGCTGAACACCATCGGCGCCGGACTGGCGCACCTGCGCGACCACGTCACCGCCGCACCGGCCACCCTGCTCGCCACCGGGCTGACCGGCGGGGTCGCGGCCGGGTACGCCGCGCGCAGGGGCCAGGAGGTGGACCGGCTGGTGCTGATCAACCCGCTGATCGACTACCAGGAGCACTTCGCCGACTCCCGTCCCGGCTGGCCCGCCGAGCTGTGCGCGAGCGACCGGCTGCGGGTCTCCCCCACCTTCGCGGTGGGCAGGGCGATGCTCAACGAGGTGTTCTGGCTCCAGCCGCGCGGTGCCCTGGGCGCCATCGCCGCACCGACGCTGATCATCCACGGAGCGGGGCCGACGACCGTCCCGCTGACGTCCTCCCAGACCGCTGCCGAAGCACTCACGTGCGCAAGCCGCCTCGTCGAGATCAACGGTCCGCAGGCCCCGCACTGGCAGGCTCCCGCGATCCGCGAGGTGACGGAGTGGATCCTCCCGGCACGGTGA	MPTSTAETQQRTTVRTHDGLRLAGTLVAPEPEPKRAVLLLHGEGSTSDQGGFYARLSAELAERGVASLRFDLPGHGDSEGRQEDLTLSGLLNTIGAGLAHLRDHVTAAPATLLATGLTGGVAAGYAARRGQEVDRLVLINPLIDYQEHFADSRPGWPAELCASDRLRVSPTFAVGRAMLNEVFWLQPRGALGAIAAPTLIIHGAGPTTVPLTSSQTAAEALTCASRLVEINGPQAPHWQAPAIREVTEWILPAR	MTETSPSSPSSATADAGTPPPADLEQLLALAADHGLDLLGDSLRTEEIGLDFRVAFARSRDWQDWVLRIPRRAEVLARAAVEGRLLAHLAPHLDIAIPDWRISTERLIAYPLLPGTPGLTVSADGTVEWHVDMASTEYARALGTFLAQLHTVDPEEAAATGIPSRTPSEVRGVWREDLTRVAEAFPIAPALRERWEAWLAEDSYWPDRSVLTHGEVYPGHTLVEGERLSAVLDWTTASVGDPARDLMFHRSSAPPEAFAATLAAYVAGGGTLHPRLGEHAEEMFSASPLAYGLYALETGEEEHRAAAAAALDPPDAD	80.13	gnl|BL_ORD_ID|2690|hsp_num:0	3219			651	867	erythromycin
BGC0001337.1|Lazarimide_2 # 943 # 1170 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.667	BGC0001337.1|Lazarimide_2 	943	1170	+	Loose	700	21.9422	ACT-81	36.36	3006275	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	GTGGATCCTCCCGGCACGGTGACGCAAAAAAAGGGGGAGCTTTCGTCCGGCAACGAGAGCTCCCCTTTTCCGCGCCAGGCCTTTTCGCGTCAGGCGGAAACCGGCCAGGCCGCTCCCGACGCACTCACATGCACCAGCCACCTCGTCGAGATCAACGGTCCGCAGGCCCCGCACTGGCAGGCTCCCGCCATCCGCGAAGTCGCGGAGTGGATCCTCCCGGGACGATGA	MDPPGTVTQKKGELSSGNESSPFPRQAFSRQAETGQAAPDALTCTSHLVEINGPQAPHWQAPAIREVAEWILPGR	MMKKFLCCALLLSTSCSVLAAPMSEKQLADVVERNVTPLMKAQGIPGMAVAVIYQGQPHYFTFGKADIAANKSVTPRTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPDLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANSSIGLFGTLAVKPSGMNYEQAMTTRVFKPLKLDHTWINVPKAEETHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMANMAPDALQDTSLKQGITLAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPAREVSPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPARVETAYRILDALQ	19.69	gnl|BL_ORD_ID|3133|hsp_num:0	4171			774	873	
BGC0001337.1|Lazarimide_3 # 1236 # 1715 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.704	BGC0001337.1|Lazarimide_3 	1236	1715	-	Loose	700	24.2534	norA	23.33	3000391	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAACCCTCGTTCCGGTCGCTGATGGCCGGGTTCCCGACCGGGGTCGCCGTGCTGACGACGTTCGACCTCGACGACACCCCGCGCGGCATGACGATCTCATCGGTGTGCAGCGTGTCGATGGATCCGCCGACGTTGCTGGTGTGCGTGCGCAACGGCAGCCCGACGTTGTCCGCCTTGCTGCGCAGCGGTTCCTTCACGGTCAACCTGCTGCACCACGCGGCCCGGCCGGTGGCGGAGCTGTTCTGCTCGGGTGAGCCGGACCGGTTCTCGCGGGTGTCCTGGGAGCGACCGGCGCTGGGCGGGCCGCACCTCGTGCGCGACGCCCACGCCGTGGCGGATTGCGTTGTTTCCCAGACGCAGGAGGTCGGGACGCACGTCGTGGTGTTCGGCGAGGTCCGCGAGGTCACGCACCGGTCGGCCCAGCAGCCGCTGCTGTACGGGATGCGGCAGTACGCGGCCTGGCCGGTCTCCGCCTGA	MKPSFRSLMAGFPTGVAVLTTFDLDDTPRGMTISSVCSVSMDPPTLLVCVRNGSPTLSALLRSGSFTVNLLHHAARPVAELFCSGEPDRFSRVSWERPALGGPHLVRDAHAVADCVVSQTQEVGTHVVVFGEVREVTHRSAQQPLLYGMRQYAAWPVSA	MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGTLADKLGKKLIICIGLVFFAVSEFMFAAGQSFTILIISRVLGGFSAGMVMPGVTGMIADISPGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYVAGTLGVVAFIMSVLLIHNPQKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDISIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISFVVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLYMAIAVSLSGIIIIFIEKGLKSRRKEAN	41.09	gnl|BL_ORD_ID|1427|hsp_num:0	1554			516	606	ciprofloxacin; acriflavine; norfloxacin
BGC0001337.1|Lazarimide_4 # 1712 # 2197 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.720	BGC0001337.1|Lazarimide_4 	1712	2197	-	Loose	500	25.409	OXA-627	42.86	3005848	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGCCGGCAACGGGGTGCACGCGCTGGGGCTGACGCCGATCTTCGGTGCGTTCCTGGCCGGCCTGATGATCCCGAAGGGCCCGGCGTGGGAGCGCGTGGCCGGACTGATCGGCGGGACCGGGCGGGTGTTCGTCCCGGTGTTCTTCGTGGTGGCCGGCATGACGCTGGCGACGGGCGGGATCGGCGCCCTGCCGTGGTCCGGGGTCGTGCTGGCGGTGCTGCTCGGGATCGCGGGCAAGGTCGGCGGCGGATACCTCGGGGCTCGGTGGGGCGGCGAGGACCGGCTGACGTCGGTGCGGATCGGCGTGCTGGTCAACACCCGCGGCCTCACCGAGATCGTGGTGCTCCAGGTCGGCTACACCGCTGGCTTGCTGACGCCGGGGTTGTTCGTGGCGCTGCTGGTGATGGCGCTGGTGACGACCACGTTGACCGGGCCGCTGCTCGATCTGATCGTCCGTCGCCGGGTGCTCCTGGAGGTCCGATGA	MAGNGVHALGLTPIFGAFLAGLMIPKGPAWERVAGLIGGTGRVFVPVFFVVAGMTLATGGIGALPWSGVVLAVLLGIAGKVGGGYLGARWGGEDRLTSVRIGVLVNTRGLTEIVVLQVGYTAGLLTPGLFVALLVMALVTTTLTGPLLDLIVRRRVLLEVR	MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDAGLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN	64.92	gnl|BL_ORD_ID|3883|hsp_num:0	4953			273	336	cloxacillin; oxacillin; cefalotin
BGC0001337.1|Lazarimide_5 # 2164 # 2931 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.733	BGC0001337.1|Lazarimide_5 	2164	2931	-	Loose	730	30.0314	tet(G)	29.5	3000174	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAGAACTTCCTTCATCTGGTCGCGTTGCTGGCGGCACTGTTCGCGGTCGCGGCCGCGGGGCGCTTCCTCGCCAGGCTGCTGCGGCTGCCCTCGGTGATCGGTGAGATCGCGCTGAGCGTCCTGCTCGGCCCGGTGCTCCTGCACGCGTTCGGCCCCGCCGTCTTCGCCGCCGTGCTGCCCGCGGACGTCATGGGCCTGCTGAGACACGTCGGTGAGGCCGGGCTGGTGCTGTTCCTGGTGGGCATCGTGCACCAGCTCGACCACGGGGTGAACGGGTTGCGCGGCAAGGCGGTCGGGCGGATCACGCTCGGCGCGTTCGCCCTGCCGCTGCTGACCGGGCTCGTGTTCGCGGCGTGGGTGCTGTGGCTGGCACCGGCCGAGGTGCGCGGCACGGCGGACGCGGGCGCGCTGGTGCTCATGCTGGCCGTCGCGATGAGCGTGACCGCGGTGCCGGTGCTGGCGCGGATCGTCGAGGAACGCCGTGCGGAGCTCGGCCGGTCCGCGGACCTGTCGATGATGGCGTCGATGCTGATCGACACGCCCGCGTGGCTGCTGCTGGCCGTTGCCCTCGGGCTCGCCGCCGGTGGACTCGGCGGTGTCTGGGTGGCGCTCGCGGCCATCGCGGCCGGCGGGATGCTGGCGTTCCTCGGGTTCCGGCTCCTCGGCCGGTTAGACGTCCGGGCGAGCACCTACCGCGGATCTTCGCGGGGCTGCTCGGGCTGGTGGCGCTCGTGGCCGGCAACGGGGTGCACGCGCTGGGGCTGA	MQNFLHLVALLAALFAVAAAGRFLARLLRLPSVIGEIALSVLLGPVLLHAFGPAVFAAVLPADVMGLLRHVGEAGLVLFLVGIVHQLDHGVNGLRGKAVGRITLGAFALPLLTGLVFAAWVLWLAPAEVRGTADAGALVLMLAVAMSVTAVPVLARIVEERRAELGRSADLSMMASMLIDTPAWLLLAVALGLAAGGLGGVWVALAAIAAGGMLAFLGFRLLGRLDVRASTYRGSSRGCSGWWRSWPATGCTRWG	MRSSAIIALLIVGLDAIGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVCAPLLGQFSDGYGRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRLISGITGATGAVAASTIADSTGEGSRARWFGYMGACYGTGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLKETNRSHGETGKLVRIEPFVLFRLDDALRGLTALFAVFFTIQLIGQVPAALWVIYGEDRFQWDTTTVGLSLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFILLAFATQGWMVFPILLLLAAGGVGMPALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSATIGAWTGWVWIVGAILYLICLPILRRPFATSL	65.22	gnl|BL_ORD_ID|893|hsp_num:0	957			549	942	tetracycline
BGC0001337.1|Lazarimide_6 # 2944 # 4482 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.669	BGC0001337.1|Lazarimide_6 	2944	4482	-	Loose	850	28.4906	OpmH	28.26	3003682	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGAAGAGTGTTGTGATCGTGGGCGGTGGAACGTCGGGCTGGATGACGGCTTCGTACCTGACCGCGGCGTTCGGTGACCGGATCGAGGTCACGCTGGTGGAGTCGGCGCGGGTCGGCGCGATCGGCGTCGGCGAGGCCACGTTCAGCACCGTCCGGCACTTCTTCGAATACCTCGGTCTCGAGGAGAAGGACTGGATGCCGGCGTGCAACGCGACCTACAAGCTCGCGATCCGGTTCGAGAACTGGCGCGAGGAGGGCCACCACTTCTACCACCCGTTCGAACGGCAGCGGGTGGTGGACGGGTTCACGCTGCCGGACTGGTGGCTGCGCAACCCGTCGTCGGACCGGTTCGACCGGGACTGCTTCCTCGTGGGCACGTTGTGCGACAGCCTGAAGTCACCGCGGCACCTGGACGGCACGCTGTTCGAGGGCGGCCTGGGGGAGCGGTCGACGTACCGGACGACGCTGTCCGAGCAGTCGACCCAGTTCCCGTACGCCTACCACTTCGACGCCACATTGGTCGCGAACTTCCTGCGCGACTACGCGGTCGCGCGCGGCGTCCGGCACGTGCTCGACGACGTGGTCGACGTGGCGCTGGACTCGCGGGGCTGGATCAGTCACGTCGTGACCAAGGAGCGGGGCGAGCTCGCCGGCGACCTGTTCATCGACTGCACCGGCTTCCGGAGTCTGTTGCTGGGCAAGGCTCTCGAGGAACCGTTCGAGTCGTACCAGTCCTCACTGCCGAACGACTCGGCGGTGGCGTTGCGGGTGCCGCTCGACATGGAGCGCAAGGGGTTGCGGCCGTGCACCACCGCGACCGCGCAGGAAGCCGGCTGGATCTGGACGATCCCGCTGTTCGACCGCATCGGCACCGGGTACGTCTACGCCAGCGAGTACTCCACACCCGAGCAGGCCGAGCAGCGGCTGCGCGAGTTCGTCGGTCCAGCGGCGGAAGGCCTGGAGGCCAACCACATCAAGATGCGGATCGGCCGTTCGCGCCGGCACTGGGTCAACAACTGCGTCGCGATCGGCCTGTCGTCCGGCTTCGTGGAACCGCTGGAGTCGACCGGCATCTTCTTCATCCAGCACGGGATCGAGCAGCTGGTGAAGCACTTCCCGGACGTCTCGTGGGAAGACGGCCTGCGCGACTCGTACAACAACCTGGTCAACCGCTGCATGGACGGCGTGCGCGAGTTCCTGGTGCTGCACTACTACGCGGCCAAACGCGCAGACAACCAGTACTGGCAGGACACCAAGAACCGCGCGTTGCCGGACGGTCTCGCGGAACGCCTGGAGCGGTGGAAGACCCGGCTGCCCGACGCCGAGTCGGTCTACCCGCACTACCACGGCTTCGAGGCCTACTCCTACGTCTGCATGCTGCTCGGGCTCGGCGGCGTCGAGCTGAAGCCCTCGCCGGCGCTCGGCCTGCTCGACCCGTCGTCGGCGCAACACGAGTTCAAACTCGTCGCCGAACAGGCCACCGAGCTCGAACGGACGCTGCCCACGCAGTACGAGTACTTCGCGCGGTTGCGCTGA	MLKSVVIVGGGTSGWMTASYLTAAFGDRIEVTLVESARVGAIGVGEATFSTVRHFFEYLGLEEKDWMPACNATYKLAIRFENWREEGHHFYHPFERQRVVDGFTLPDWWLRNPSSDRFDRDCFLVGTLCDSLKSPRHLDGTLFEGGLGERSTYRTTLSEQSTQFPYAYHFDATLVANFLRDYAVARGVRHVLDDVVDVALDSRGWISHVVTKERGELAGDLFIDCTGFRSLLLGKALEEPFESYQSSLPNDSAVALRVPLDMERKGLRPCTTATAQEAGWIWTIPLFDRIGTGYVYASEYSTPEQAEQRLREFVGPAAEGLEANHIKMRIGRSRRHWVNNCVAIGLSSGFVEPLESTGIFFIQHGIEQLVKHFPDVSWEDGLRDSYNNLVNRCMDGVREFLVLHYYAAKRADNQYWQDTKNRALPDGLAERLERWKTRLPDAESVYPHYHGFEAYSYVCMLLGLGGVELKPSPALGLLDPSSAQHEFKLVAEQATELERTLPTQYEYFARLR	MLRRLSLAAAVAAATGVAWAAQPTPLPTKTDLISVYKEAVDNNADLAAAQADYLARKEVVPQARAGLLPQLGAGARVGDTRIAFDERPATVKRNSQVVQATLSQPLFRADRWFQWQAAKETSDQARLEFSATQQDLILRSAETYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLSDKTDVLEAQASYDTARANRLIAEQRVDDAFQALVTLTNRDYSAIEGMRHTLPVVPPAPNDAKAWVDTAVQQNLRLLASNYAVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSAANPLVHYGKYVDERSIGLELNIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTRNLHRAVNTDVEQVQARRQAIISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNNSRYDYILDTLRLKQAAGTLSPADLEALSAYLKQDYDPDKDFLPPDLAKAAAEQLQSKPRQQY	106.22	gnl|BL_ORD_ID|2005|hsp_num:0	2195			654	792	triclosan
BGC0001337.1|Lazarimide_7 # 4519 # 5520 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.701	BGC0001337.1|Lazarimide_7 	4519	5520	-	Loose	400	30.8018	ErmW	27.08	3001306	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACGCCGCTGGCGCACCGGATGATGCAGATGATCACCGGGTACTGGGTGACTCAGATCGTGCACGCCCTCGCCGAACTGAAGATCGCCGACCACCTCGCGGACGACCGGCTCACCGCCGGCGAACTCGCCGCGCTGACCCGGTCCGACGCCGACGCGATGTTCCGGCTGTTGCGCGCCGCCGCGTCGCTGGAGCTCGCCTCCTACGACGGCGACGGCCGGTTCGGCAGCACGCCGTTGCTGGAGATGCTGCGCGAGGGCGTACCGCATTCGTTGCGGGACATCGCGATCGTGAACGGCTCTCCCGCGCACTGGCTGTCCTGGGGCAGGTTCCCCGACGCGGTCAGGGCCGGTGAACCGCAGACGAAGGCGGCGCTGGGCAGTGACGTGTGGGCCTACTTCGCGGCGAACCCGGAGGAGTTCGAACTGTTCTCCCGCTCGATGACCGAGCTGTCCGAGGGACTGTGCCACGAGATCGCGGAGCTGCTCGACACGACCGGCGTCGCGACCGCGGTCGACGTCGGCGGTGGCAACGGCACGTTGCTGCACGCGCTGATGAAGTCCGATGCGGACCTCCGGGGTGTGGTCCTCGACCTGCCGGGCGTGGCGCCGACGGCGATCGCCGCGGCGGACGAGGCTGGGCTGAGCGACCGCTGCGAGTTCGTCGGCGGTTCCTTCTTTGACACGGTGCCGGAAGGCGACCTGTTCCTGCTCAAAGCCGTGCTGCACAACTGGGCCGACGATTCGTGCGTCGAGATCCTCACCCGCTGCCGCGAGGCGATGCGCCCCGGCGGCCGGGTGGTGGTCGTCGAGATGCCGCTCGGCCCGGTCGGTGAGCCCGGCTTCGCACCGTTGCTGGACCTCAACATGCTCGCGGTCGTGCCCGGCCGGGAACGCGATCTCGCGCACTACGACGCCCTGTTCGCGGCCGCGGGACTGCGGCGGGCGAACCTCACCCCCACCCGTTCCCCGCAAAGCCTGATCGAAGCCGTCGCCGAGTGA	MTPLAHRMMQMITGYWVTQIVHALAELKIADHLADDRLTAGELAALTRSDADAMFRLLRAAASLELASYDGDGRFGSTPLLEMLREGVPHSLRDIAIVNGSPAHWLSWGRFPDAVRAGEPQTKAALGSDVWAYFAANPEEFELFSRSMTELSEGLCHEIAELLDTTGVATAVDVGGGNGTLLHALMKSDADLRGVVLDLPGVAPTAIAAADEAGLSDRCEFVGGSFFDTVPEGDLFLLKAVLHNWADDSCVEILTRCREAMRPGGRVVVVEMPLGPVGEPGFAPLLDLNMLAVVPGRERDLAHYDALFAAAGLRRANLTPTRSPQSLIEAVAE	MSSIRRRHAAASLDTPAVGGRHELGQNFLVDRGVCTRIAEVVSSTTAHPVLELGAGDGAITRALVAANLPVTALELDPRRVRRLQRTFADGVTVVHGDMLRYDFGPYPHHVVSTVPFSITTPLLRRLIGQRFWHTAVLLVQWEVARKRAGVGGTTMLTAASWPWYEFTLVERVPKTSFDPVPSVDGGILVIERRSAPLLDDRCVGDYQNLVREVYTGPGRGLAAILRTRLPGREVDAWLRRERVDPAALPRDLKAGHWASLYRLYREVGTRPAPAGRSVRARPGSVGPDRSLPPRGLRSGPPRARRRGGGA	107.07	gnl|BL_ORD_ID|1572|hsp_num:0	1714			87	231	erythromycin; josamycin
BGC0001337.1|Lazarimide_8 # 5517 # 6713 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.708	BGC0001337.1|Lazarimide_8 	5517	6713	-	Loose	550	47.7506	Nocardia farcinica rox	28.39	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCTGGGGCTGCTGCTCGCGCGGTCCGGAGTGGACGTGGTGGTGCTGGAGAAGCACGCGGACTTCCACCGCGACTTCCGCGGCGACACGGTGCACCCCGCCACGCTGCAGATCCTCGACGAACTCGGCCTGGCGGAACGGTTCCACGAGCTGCCGCACCAGAAGGTCGCCACGATCGGCGTGGTGCAGGACGGCAGGCGCATCGACATCGCCGACTTCCGCAGGCTGCGGGTGCGCTACCCGTACATGGCCTTCGTGCCGCAGTGGGACTTCCTCGACCTGATCACCACCGAGGCCGCGCGCTACCCCGGCTTCCGGCTGATGATGAGCACCGAGGTCCTCGGTGTGGTGCGGGAGGACGGCCGGGTCGCCGGTGTCCGGGCGCGGGGGCCGCAGGGCGAGTTCGAGGTCCGTTCGACCCTGGTGGTCGCCGCCGACGGCCGGCACTCCGCGATCCGCGGGGACGTCGGCGTGACGCCCCGGCAGATCGGCAAGTCGCTGGACGTGATCTTCTTCCGGCTCTCCCGCCGGGACACCGACCCCGACGAGGGTCTCTGCGTGCGCGTCGGCAACGGCAAGGTGTTCGGCGCCACCGACCGCAGGACGTACTGGCAGATGTTCACCGAGACCACCAAAGGCGGCTACGAGAAGGTGCGCCGGGACGGGCTCGACGCGTTCCGCGCGGATCTTGCCGCTGCCGTGCCGTTCCTCGCCGACCGCGTGCACGAAGTGTCCTCGTGGGACGACCTGAAGCTGCTGGAGGCGCGGATCGACCGGCTCGACCGCTGGCACCGGCCCGGCCTGCTGTTCATCGGCGACGCCGCGCACGCCATGTCGCCGGTCGCGGGCTTCGGTGTGAACCTCGCGGTGCAGGACGCGGTCGCCACGGCCAACGCCCTGGTCGCACCACTGCTCACCACGCAACTGACCGGTGCCGCGTTCGACGACTCGCTGCTCGCCGCCGTCCAGCGCCGCAGGCGGCTCACCACCACGCTGTCGCAGGGACTTCAGCGGGCGACCCAGCGCTTCGGCATCGACGAGGCGCTCGATGGCTCCGGGCAGCCGCCCGCGCCCAAGTTGTTCGAGTGGTTCGCTCCGGCGCAGTGGCTGATGAGCCGCGTCATCGGCCTCGGCTTTCGCCCCGAACACGTGCGCACACCCGTGACGGCGCAGCTACCCGAAGGGAAGACCTCATGA	MLGLLLARSGVDVVVLEKHADFHRDFRGDTVHPATLQILDELGLAERFHELPHQKVATIGVVQDGRRIDIADFRRLRVRYPYMAFVPQWDFLDLITTEAARYPGFRLMMSTEVLGVVREDGRVAGVRARGPQGEFEVRSTLVVAADGRHSAIRGDVGVTPRQIGKSLDVIFFRLSRRDTDPDEGLCVRVGNGKVFGATDRRTYWQMFTETTKGGYEKVRRDGLDAFRADLAAAVPFLADRVHEVSSWDDLKLLEARIDRLDRWHRPGLLFIGDAAHAMSPVAGFGVNLAVQDAVATANALVAPLLTTQLTGAAFDDSLLAAVQRRRRLTTTLSQGLQRATQRFGIDEALDGSGQPPAPKLFEWFAPAQWLMSRVIGLGFRPEHVRTPVTAQLPEGKTS	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	84.14	gnl|BL_ORD_ID|4834|hsp_num:0	5821			42	921	rifampin
BGC0001337.1|Lazarimide_9 # 6775 # 8367 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.679	BGC0001337.1|Lazarimide_9 	6775	8367	-	Loose	690	25.7942	MexJ	39.29	3003692	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGAAGATCATCGGATCAGGAAGGTCGTCGTCCTCGGCGGTGGCACCGCGGGCTGGATGACAGCCTCCTACCTCGGCAAAGCGCTCGGACCTGACGTCGCGCTCACCGTGCTCGAGGCGCCGTCCATCCCGAAGATCGGGGTCGGCGAGGCCACCGTGCCGAACCTGCACAGGACGTTCTTCGACTTCCTCGGCCTCGCCGAGGACGAGTGGATGCGGGAGTGCAACGCCAGCTACAAGATGGGCGTCCGGTTCATCAACTGGCGCACCCCTGGCGCCGGCGAGGCGAAGGCGCGGGAGCTGCGCGGCAAGCCGGACCACTTCGACCACCTCTTCGGCCTGCTGCCCAACCACGCGAACCTGCCGCTGTCGCACTACTGGACGGCCGAGCGGCTGGCCGGCCGCACCGACGAGGCGTTCGACTACGCCTGCTACCGCGAGTCGCCGGTGCTGGACGCCGCACTCGCGCCCCGTCACGCCGACGGGTCCCGGTGGACGAACTACGCGTGGCACTTCGACGCGCACCTCGTGGCCGACTTCCTGCGCCGGTTCGCCACCGAGCGGCAGGGCGCGCTCCACGTCGAGGACGAGATGACCGAACCGGTCATCGACCACCGCGGGCACATCACCGCGTTGCGCACGAAGTCCGGCCGCCTGATCGAGGGCGACCTGTTCGTCGACTGCTCGGGTTTCCGCGGCCTGCTCATCAACAAGGCGATGCGCGAGCCGTTCCTCGACATGAGCGACCACCTGCTCAACGACAGCGCGGTCGCCACGGCCGTGCCGCACGACGACGAGGCCAACGGCGTCGAGCCGTACACCTCGGCGATCGCGATGAGCCACGGGTGGACGTGGAAGATCCCGATGCTGGGCCGGTTCGGCACCGGCTACGTCTACTCGAGCCGCTTCACCTCGCCGGACGAGGCGACGAAGGAACTCTGCGACATGTGGGGCCTCGACCCCGAGACGCAGCCGCTCAACCACGTGAAGTTCCGCGTCGGCCGCAACCGCCGCACGTGGGTGCGCAACGTCGTCAGCATCGGGTTGTCGTCGTGCTTCCTGGAGCCGCTCGAGTCCACCGGCATCTACTTCATCACCGCGGCGCTCTACCAGCTGGCGAAGCACTTCCCGGACAAGCGGTTCGACCCGGTGCTGGCCGACTCGTTCAACCGCGAGATCGAGACCATGTTCGACGACAGCCGCGACTTCCTGCAGGCGCACTTCTCGCTGGCGCCGCGGCAGGACACGGTGTTCTGGCGGTCCTGCAAGGAACTGGAGCTGGCGGAGAACTTCAAGGGCAAGCTCGCGGCGTACCGCGCGGGTCTCGCGGTGAACATGCCCGCCGTCGACGAGACGACCTACTACGCGAACTTCGAGGCGGAGTTCCGCAACTACTGGACCAACAGCAGCTACTACTGCATCTTCGCCGGCCTCGACTACCTGCCGGAGCACCCGTTGCCGTTGCTCGACCAGCGCGGCGACCTGGTGGCGGGAGCGGAACCGGTGTTCGCGGAGATGAAGCGCAAGCAGAAGGAACTGCTCGCCGGGCTGCCGACCCACTACGACCACCTGCGCCGGCTGCACGGGCGCTGA	MEDHRIRKVVVLGGGTAGWMTASYLGKALGPDVALTVLEAPSIPKIGVGEATVPNLHRTFFDFLGLAEDEWMRECNASYKMGVRFINWRTPGAGEAKARELRGKPDHFDHLFGLLPNHANLPLSHYWTAERLAGRTDEAFDYACYRESPVLDAALAPRHADGSRWTNYAWHFDAHLVADFLRRFATERQGALHVEDEMTEPVIDHRGHITALRTKSGRLIEGDLFVDCSGFRGLLINKAMREPFLDMSDHLLNDSAVATAVPHDDEANGVEPYTSAIAMSHGWTWKIPMLGRFGTGYVYSSRFTSPDEATKELCDMWGLDPETQPLNHVKFRVGRNRRTWVRNVVSIGLSSCFLEPLESTGIYFITAALYQLAKHFPDKRFDPVLADSFNREIETMFDDSRDFLQAHFSLAPRQDTVFWRSCKELELAENFKGKLAAYRAGLAVNMPAVDETTYYANFEAEFRNYWTNSSYYCIFAGLDYLPEHPLPLLDQRGDLVAGAEPVFAEMKRKQKELLAGLPTHYDHLRRLHGR	MYRHIPLVALSLFSSLFLAACGNGTPPPAAARPAIVVQPQPAGEVSQAFPGEIRARHEPELAFRIGGKVIRRLVEVGERVKKDQPLAELDPQDVRLQLEAARAQVSAAEANLQTVRAEYRRYRTLLDRNLVSHSQFENIQNSYRAGEARLKQIRAEFNVADNQAGYAVLRSPQDGVIASRRVEVGQVVAAGQTVFSLAADGEREVLIGLPEHSFERFRIGQPVSVELWSQRDRRFAGHIRELSPAADPQSRTFAARVAFDDRATPAELGQSARVYVAAAEAVPLSVPLSALTAEAGQAFVWVVEPGSSTLRRQAVRTGPYAEDRVPVLEGLKAGDWVVATGVQVLREGQQVRPIDRANRTVKLAAKE	144.41	gnl|BL_ORD_ID|2015|hsp_num:0	2205			552	636	erythromycin; tetracycline; triclosan
BGC0001337.1|Lazarimide_10 # 8577 # 10004 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.703	BGC0001337.1|Lazarimide_10 	8577	10004	+	Loose	750	32.7278	tet(X6)	37.5	3005056	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGTCAGCGCGCAAGAAGGTCACGGTTCTCGGTGCGGGGATGGCGGGTCTCGTGGCCGCGCACGAACTCGAGCAACTGGGCCACGAGGTCGAGGTGATCGAGGGAAGCGGGCGGCTCGGCGGCCGGGTGTACACGCACCGGTTCGGTGCGGGTCCCTCGGCGCCGCTGGTCGAGCTGGGCGCCATGCGGATTCCCGCACAGCACCGGCACACCCTGGCCTACGTCGAGAAGCTCGGCCTGTCGCACAAGCTCCGCGAGTTCAAGACGCTCTTCTCCGACGACAGCGCCTACCACCACACCCGCACCGGGTTCGTGCGCGTGCGGGAGGCGGCCAAGGCGCTCGTGGCCGACTACCGGGAGTTCCTGGGCGAGGGCCTGCGCGAGGAGACCGTCCTGTTCGGTGCGTGGATCACCGCCATCGGTGACGCGATCGCGCCCGGCAGCTTCATGGAGTCGCTGCGCCCCGACTTCGCCGCGCTGCTCGAGGCCGTCGACCGCATCGACCTGACCCCGTTCCTGGTGGGCGAGGGACGGGACCAGGTCGACCTGCACGCGTTCTTCGCGGCCCATCCCGAGGTGCGGCAGAGCGGCACGGGCCGGATCAACCACTTCATCGGTGACATCCTCGACGAGACCAGTCCAGGGCTGATGCGGCTCGAGGGCGGGATGGACCAGATCGTCGACGCTCTCGCGAGCCGCATCTCCGGGCCGATCCGCCTCCACCACGAGGTGCGCGGGATCGCCGTGCACGACGACCACGTCGCCGTGACCGTCTCGAATGGACAGCGGGAGATCGTCCTCCGCTGTGACCACGTGCTGAGCGCGATCCCGTTCTCCGTGCTGCGCAAGCTCGAGCTCAGCGGCTTCAGCGACGACAAGCTGGCCGTGCTCGACGAGGTCACGCACTGGCCGGCCACCAAGATCGCGTTCCTGTGCCGCGACGCGTTCTGGCAGCGCGACGGGATCACCGGCGGGGCGTCGTACGGCGGCGGGCACATCAGGCAGACCTACTACCCGGCGGTGGAGGGCGACCCGGCCAGGGGCGCCGCGCTGCTGGCGAGCTACACGATCGGCGCCGACGCCGCCGTGCTCGACGACATGCCGGAAGCGCAACGGCACGAGCTCGTGCTCGGCGAGGTCGCCACGATGCATCCCGAGCTGCTCGAACCGGGGATGATGGTCGAGGCCGTGAGCCAGCCGTGGGGCAAGCACCCGTGGAGCGCCGGTGCCGGTGTCCTGCGGTGGAACAAGGACGAGGCCGCGTGCCTGGAGGAACGCGACCGGGCGGCCCGTCCCGAGCGCGGCAGGTTGTTCTTCGCGGGTGAGCCCTGCGCGACCGTCACCGGGTGGATCGACGGCGCCATCGAGTCCGCCCTGCGCGCCGTGCGGTTCATCGAACAAGCCGAGATCCCGGAGAGCGTCCGATGA	MSARKKVTVLGAGMAGLVAAHELEQLGHEVEVIEGSGRLGGRVYTHRFGAGPSAPLVELGAMRIPAQHRHTLAYVEKLGLSHKLREFKTLFSDDSAYHHTRTGFVRVREAAKALVADYREFLGEGLREETVLFGAWITAIGDAIAPGSFMESLRPDFAALLEAVDRIDLTPFLVGEGRDQVDLHAFFAAHPEVRQSGTGRINHFIGDILDETSPGLMRLEGGMDQIVDALASRISGPIRLHHEVRGIAVHDDHVAVTVSNGQREIVLRCDHVLSAIPFSVLRKLELSGFSDDKLAVLDEVTHWPATKIAFLCRDAFWQRDGITGGASYGGGHIRQTYYPAVEGDPARGAALLASYTIGADAAVLDDMPEAQRHELVLGEVATMHPELLEPGMMVEAVSQPWGKHPWSAGAGVLRWNKDEAACLEERDRAARPERGRLFFAGEPCATVTGWIDGAIESALRAVRFIEQAEIPESVR	MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL	125.66	gnl|BL_ORD_ID|4802|hsp_num:0	3797			18	138	tetracycline; minocycline; oxytetracycline
BGC0001337.1|Lazarimide_12 # 12927 # 14024 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.688	BGC0001337.1|Lazarimide_12 	12927	14024	-	Loose	2300	33.4982	evgS	25.62	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGAACAGATCCAGCTCCCCGACGGCAAAAAGGTCTGGCTCGTCTCGGACTACGCGGGCACCCGGAGCGTCCTGACCGATTCCCGGCTCACCAACGATCCGTTGCGCATGGGCGACAAGGCCCCGTTCTCCGCGTTCCCGGAGTCGATCGCCTCGGTGATGGCGCACGACATGCTGAACAACGACCCACCGGCGCACACCCGGCTGCGCCGCCTGGTCACCCCGACGTTCACCGTGCGCCGGATCGCCGACCACCGCCCGCAGGTCGAGCGGATCGCCGCCGAGCTCATCGAGCACTTCGGTGACCGGCCCGATCTGGTGCGGGACTTCGCCGGACCGTTGGCGACGAAGGTGCTCGGGCTGATGCTCGGCATCGACCCCGCGGACGCGGCGCGGGTGCGGTACTGGTCCGACCTGTTCGTGCTGGACCTGTTGACGCGCAACGAAGAGGCGATGGACGCCACCCACCGCCTCGCCGAGTACACCAGGGGTCTCGTGGACGAGCGCCGCCGGAATCCGGGTGACGACCTGGTGTCCCGGCTGGTGTCGATGCGGGACGACGAGGAACGCCTCGACGACCACGAGCTCGCCTCGATGGTGTTCACCCTGGTGATCGGCGGCCAGACGGCGACGACCCAGTTGCTCGCCAAGGCGTTGTACCTGCTGCTGAACCACCCGGACCAGCTGGAACTGCTGCTGGCGGACTGGAGTCTGCTGCCGTCGGCCGTGCACGAGGTGTTGCGGATCGACCCGCCGCTGCAGATGACGTCGTTCCGGATGGCGACCGAGCCGTTCGAGTTCGACGGCAAAACCGTGCAGCAAGGAGACATCGTGGTGTGCGCGCTGCGGGAGGCGAACCGGGATCCGGTCAGGTTCACCGACCCGGAGCGGTTCGACCTGCGCAAGGGCGACGGTCAGCACCTGGGGTTCGGTCACGGCGTGCACCGGTGCATCGGCGCGAACCTCGCGGAGCTCCAGTGCCAGGTCGGCCTCACGGCGTTCTTCCGCCGCTTCCCGCACGCCAAGCCCGGCGAGGCGGAGTGGCGGCAGACGCCGTTGATCACGGCGATCAGCGCGCTGCCGGTCCACCTCAGCTGA	MEQIQLPDGKKVWLVSDYAGTRSVLTDSRLTNDPLRMGDKAPFSAFPESIASVMAHDMLNNDPPAHTRLRRLVTPTFTVRRIADHRPQVERIAAELIEHFGDRPDLVRDFAGPLATKVLGLMLGIDPADAARVRYWSDLFVLDLLTRNEEAMDATHRLAEYTRGLVDERRRNPGDDLVSRLVSMRDDEERLDDHELASMVFTLVIGGQTATTQLLAKALYLLLNHPDQLELLLADWSLLPSAVHEVLRIDPPLQMTSFRMATEPFEFDGKTVQQGDIVVCALREANRDPVRFTDPERFDLRKGDGQHLGFGHGVHRCIGANLAELQCQVGLTAFFRRFPHAKPGEAEWRQTPLITAISALPVHLS	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	30.49	gnl|BL_ORD_ID|1214|hsp_num:0	1318			69	423	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0001337.1|Lazarimide_13 # 14457 # 17192 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.734	BGC0001337.1|Lazarimide_13 	14457	17192	-	Loose	390	35.8094	evgA	33.93	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCGACAGCGTGGAAGAGCAACGGTCGCACGTCGTCGTGCTCGAGTCCGGCGCCGGCACCGGCAAGACCCGCCTGCTGCTCGAGCTGATGTCGTGCGCGGCCAGGCGCGGTTTCGCGGTCGTCAACGGTGCGGCGGACCAGCCGGGCCTCGCGCGGGCGGTCACCCTGGTCAACCCCCGCAACGGCAGGCAGGAGGACGACCGGATCGGCACGCTCGCCGGCCGGTTCGAGGCGCAGCTGACCGGCCACCTGCGCCGCGGGCCCGTGCTGGTGGCCGTGGACGACGTGCAGTGGACCGATCTGGCCCTGCTGCACGCGCTCGGCGCCGTCGTGTCCAAGTTGGACAGTTGCCCGGTGGTGTGGTTGTTCGCGGTGCACGCCGACCACACCGACTCGCCGAACGGAGTCGTGCTGCGCACCCTCGCGCGCAAGCACCGCGCCGAATGGCTCGGACCGCTGGAGCCGCTGACGGGCGAGGCCGTCGCGGGCATCGCGGGTGACCTGCTCGACGCGACACCGGACGACGACGTGCTCGCCCTGTGCGAGAGCGTCGGCGGCACACCGCAGGCGATCGTCGACCTGGTGCTCGACGTGCGGCGGGAAGGCTGCGTCACGGTCACCGACCAGGTGGCACGACTGGCGTCCGGGCCCATGCCGACCGGGATCTCCTCGGCGGTCGAGCCCGATCCCGGTGCGCCGCTCCCGCGTCCGTTCGTCCGGCTGATGCAGTCGAGGCTGCGGGAGCTGTCACCGCGCGCGCAGGAGGTGCTGCAGGTCGCCGCGGTGCTCGGCAGCAGTTTCGCGCCGCAGGACCTCGCCGAGATGCTGGGCGAGCGCCCGGCCCAGCTGCTCGGGCCGTTGCAGGAGGCTCTCACCGCCGGGCTGATCGGCAGCGACTCGGACGAGTTCGTGTTCCGGCGCGAACCGGTCTGGCGTGCGGTGCTCGGCACCGTGCCCGAGGTGCTGCGTTCGATGCTGCACCGGCAGGCCGCCACCATGCTGCTCGACCGTCCGCAGGGCCGGATCGAGACCGCCGCGGTGCACCTGGTGCACTGCGCGATGCCCGGCGACGCGGAGGCGATCGGTACGATCCGCGCGGCGGCGGAGCGCATGCTCGCCGGCTCGCCGCAGGCCGCGTCGGCGCTCGCGACGCGGGGACTGCGGATCGCACCACCGGACAGCGCGGACCACGCCGCGCTGGCGACCACGGCCACCGCGGCGCTGGTCCGGCTCGGGTGCCTGAGCGACGCCGTCGAGCTCGCCGAGGAGCAGCTGCGGGTGCACACCTGTCCCGAGTTGACCCGGCCGTTGCGGACGTGGCTCGCCACGGCGCTGATGCTGCGCGGCGACACCGCGGCGGCGTTCCACGTCTCGAACGAGACCATCGCCGACGCTCAGTCGCCCGCGAATTCCCTCAGTGCCGACACCGAGCCATGCCCGGAGCTGCTGCTGCTCAACGCGTTGTGCCACAACGACCAAAGCCGTGTCGTCGCCGTGGCGGACCGGGTGCTGGACGTGCCGGGCGAGCGCAGCGACGAGGTCCGTGCCGCCGCGCTGAACGTGCGGGCGATGGCGTACTGGCGCGAGGGCAGGCTCGACGCCGCGATGAACGCCGTCGACGAGGCGGTGCGGCTGCGCGGCCCGCTCACCCGCGCGTGGCAGTCCGATCCACTGTGGACAAGAGCGTGGCTGCTCACCAGGGTCCGCAGGCTCGACGAGGCGCTCGCCGCGGCCGACGCCGCCCGCAGGGCCATCGACACCGAGCACAACGGCGTGCTCAGCCCGGTTCCGCTCGCACTCCGCGCGACGATCCTGCTCGCCAAGGGCGACCTGGCCGCCGCCGAGTCGGACGCGACGGCCGGGCTCACCGCCTCCGAACGCGCGGAGATGCCGCTGTACGAACCACAGCTGCACGCGGTTCTGGTCATCTCGGCGTTGCGGCGCGGCGACCTGGCCACGGCCTCCGACGGCCTGCGCAGGCTGGAGGAGTGCGCACCGGCAGAGCGCGCACAACCGTGGACGCCGCTGGTGCGCGTGCTCTCCGCACTGGTCACCTCGGCACGGCGCGACGTGCACGCGGCGATGGAGGAACTCCGCGAGCCGCTCGCGGATCCCGGCCAGCGCCGCCAGCTGTTGCTGGAGGACCCGTCGATGACGGCGTGGGTGGTGCGCACCGCGCTGGCCGCCGATGCCAGGGAGATCGCCGAGGGCGTGGTCGTCGCCGCCGAGAAGATCGCCGCGGAGAACCAGCGCTACGTCACGATCGTCGCCGCCGCCCGGCACGGCAGGGCGCTGCTCGACAGCGACGTCAGCGCTCTGTCCGGACTCGAGGAGCGCTACGGCGACCCGTGGGCGGCGGCGTCGGTGATCGAGGACACCGGCACGCTGCTGCGCGACACCGACCGGGACCACGCCGTCGCCGAGCTGAACCGGGCGATGGCCGCCTACGACGAGCTCGGCGCGGAGTGGGACTCGGCACGCGTTCGGCGCAAGCTGCGCAGGCTCGGCGTGCGCAGGCGGCACTGGAACCACGAGGTCCGGCCGGAGACCGGATGGGGCAGCCTCACCAGCACCGAGGCGAAGGTCGCGCGGCTGGTGGCGCGGGGGCTGACCAACCGGCAGGTGGCGAGCGAGATGTTCGTGTCGCCGCACACCGTCGGATTCCACCTGCGCCAGATCTACCGCAAGCTCTCCATCCAGTCGCGGGTGGACCTCGCGCGGATCGCGCCGTGA	MRDSVEEQRSHVVVLESGAGTGKTRLLLELMSCAARRGFAVVNGAADQPGLARAVTLVNPRNGRQEDDRIGTLAGRFEAQLTGHLRRGPVLVAVDDVQWTDLALLHALGAVVSKLDSCPVVWLFAVHADHTDSPNGVVLRTLARKHRAEWLGPLEPLTGEAVAGIAGDLLDATPDDDVLALCESVGGTPQAIVDLVLDVRREGCVTVTDQVARLASGPMPTGISSAVEPDPGAPLPRPFVRLMQSRLRELSPRAQEVLQVAAVLGSSFAPQDLAEMLGERPAQLLGPLQEALTAGLIGSDSDEFVFRREPVWRAVLGTVPEVLRSMLHRQAATMLLDRPQGRIETAAVHLVHCAMPGDAEAIGTIRAAAERMLAGSPQAASALATRGLRIAPPDSADHAALATTATAALVRLGCLSDAVELAEEQLRVHTCPELTRPLRTWLATALMLRGDTAAAFHVSNETIADAQSPANSLSADTEPCPELLLLNALCHNDQSRVVAVADRVLDVPGERSDEVRAAALNVRAMAYWREGRLDAAMNAVDEAVRLRGPLTRAWQSDPLWTRAWLLTRVRRLDEALAAADAARRAIDTEHNGVLSPVPLALRATILLAKGDLAAAESDATAGLTASERAEMPLYEPQLHAVLVISALRRGDLATASDGLRRLEECAPAERAQPWTPLVRVLSALVTSARRDVHAAMEELREPLADPGQRRQLLLEDPSMTAWVVRTALAADAREIAEGVVVAAEKIAAENQRYVTIVAAARHGRALLDSDVSALSGLEERYGDPWAAASVIEDTGTLLRDTDRDHAVAELNRAMAAYDELGAEWDSARVRRKLRRLGVRRRHWNHEVRPETGWGSLTSTEAKVARLVARGLTNRQVASEMFVSPHTVGFHLRQIYRKLSIQSRVDLARIAP	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	446.57	gnl|BL_ORD_ID|936|hsp_num:0	1015			426	594	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
